Therapeutic and / or prophylactic agent for Behavioural and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with mental illness or brexpiprazol salts containing the same

• 收藏
• 分享

专利权人:

OTSUKA PHARMACEUTICAL CO.; LTD.

发明人:

KENJI MAEDA,SHINJI SATO,DAI ISHIKAWA,MAI NAKAMURA

申请号：

ARP130103867

公开号：

AR093247A1

申请日:

2013.10.24

申请国别(地区):

AR

年份:

2015

代理人:

摘要：

This refers to a Therapeutic and / or prophylactic agent for Behavioural and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with Mental Illness, which contains 7 - [4 - (benzo [b] tiofen IL - 4 - (piperazin-1-yl) - 1H - Butoxy) quinolin-2 - one or a To its Salts as active ingredient.Claim 1: a method for the prophylaxis and / or treatment of behavioural and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with Mental Illness.Characterized in that it comprises the Administration of 7 - [4 - (benzo [b] tiofen IL - 4 - (piperazin-1-yl) - 1H - Butoxy) quinolin-2 - one or one of its Salts in a therapeutically effective amount profil u00e1tica or a patient who needs the prophylaxis and / or treatment Behavioral and psychological symptoms S associated with neurodegenerative disease or impulsive symptoms associated with Mental Illness.Claim 51: a Pharmaceutical composition for use in the prophylaxis and / or treatment of behavioural and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with Mental Illness, characterized in that it comprises 7 - [4 - (benzo [b] tiofen - 4 - il - PI Perazin - 1 - il) - 1H - Butoxy) quinolin-2 - one or one of its Salts as active ingredient.La presente se refiere a un agente profiláctico y/o terapéutico para los síntomas conductuales y psicológicos asociados con enfermedad neurodegenerativa o síntomas impulsivos asociados con enfermedad mental, que contiene 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoxi)-1H-quinolin-2-ona o una de sus sales como un ingrediente activo. Reivindicación 1: Un método para la profilaxis y/o el tratamiento de síntomas conductuales y psicológicos asociados con enfermedad neurodegenerativa o síntomas impulsivos asociados con enfermedad mental, caracterizado porque comprende la administración de 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoxi}-1H-quinolin-2-ona o una

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/